CVRx Investor Relations Material
Latest events
Q1 2025
CVRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CVRx Inc
Access all reports
CVRx Inc. is a medical device company focused on developing neuromodulation technologies for cardiovascular conditions. The company’s implantable systems are designed to stimulate specific nerves to address heart failure and hypertension. CVRx markets its products to healthcare providers through a direct sales force and distribution network. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Key slides for CVRx Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
CVRx Inc
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
CVRX
Country
🇺🇸 United States